May 25, 2018

FDA Inspection

May 22, 2018

Bioanalytical Laboratory

Due to the nature of the industry in which we operate, we must always excel to achieve high quality standards that meet the needs and obligations of the pharmaceutical sector and the various authorities that regulate this environment.

We are pleased to announce that following our first Food and Drug Administration (FDA) inspection, no notice of non-compliance which would constitute an FDA violation (form-483) was issued! The inspection was held on May 22 to May 25 at our Royalmount site in the bioanalytical laboratory.

This inspection confirms that our quality standards are well established and conveyed in our everyday behavior. We are proud of our commitment to ensuring continuity in the excellence of our product quality and compliance with standards that encompass our procedures. It is this commitment that permits us to remain, to this day, among the leaders in the industry!